Kissei Pharmaceutical Co., Ltd.
Kissei Pharmaceutical Co., Ltd.
Explore linked clinical trials.6 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Confirmatory Study 3 of KPS-0373 in Patients With Spinocerebellar Degeneration | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Spinocerebellar Degenerations, brain disorder, central nervous system disorder, cerebellar disorder, hereditary disease, inherited neurodegenerative disorder, nervous system disorder, neurodegenerative disease, spinal cord disorder | Active, not recruiting | Phase 3 | 2026-09-04 | NCT07040137 | |
| A Clinical Trial of Olutasidenib in Patients With Acute Myeloid Leukemia | Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence | Recruiting | Phase 2 | 2026-05-27 | NCT07604064 | |
| A Clinical Study of KLH-2109 in Patients With Endometriosis | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Urogenital Diseases, endometriosis, female reproductive system disorder | Active, not recruiting | Phase 3 | 2026-03-02 | NCT07015268 | |
| Avacopan vs Reduced-dose Glucocorticoids in ANCA-associated Vasculitis | Cerebral Small Vessel Diseases, Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, granulomatosis with polyangiitis, immune system disorder, interstitial lung disease, lung disorder, microscopic polyangiitis, necrotizing vasculitis, nervous system disorder, respiratory system disorder, skin disorder, skin vascular disease, vascular disorder, vasculitis | Recruiting | Phase 4 | 2025-05-04 | NCT06611696 | |
| Special Drug Use-results Survey for Long-term Use（Avacopan） | Cerebral Small Vessel Diseases, Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, granulomatosis with polyangiitis, immune system disorder, interstitial lung disease, lung disorder, microscopic polyangiitis, necrotizing vasculitis, nervous system disorder, respiratory system disorder, skin disorder, skin vascular disease, vascular disorder, vasculitis | Recruiting | Not stated | 2025-01-17 | NCT06758271 | |
| Special Drug Use-results Survey for Long-term Use (Fostamatinib) | Chronic Idiopathic Thrombocytopenic Purpura | Recruiting | Not stated | 2025-01-03 | NCT06757257 |